This was the stock's second consecutive day of losses.

BRISTOL, Va. — May 9, 2025 — Universal Fiber Systems℠ LLC is pleased to announce the appointment of Jonathan Craig as CEO, ...

Lecanemab was approved in the U.S. in 2023 as the world's first drug to slow the cognitive decline associated with Alzheimer's. The treatment also has received approval in Japan, China, Europe and ...

Biogen beat first-quarter profit and revenue expectations on Thursday, as strong demand for its rare disease drugs helped ...

Burdened by competitive pressures for its stalwart multiple sclerosis franchise, Biogen has weathered years of sales declines ...

Announcing first-quarter results, Biogen CEO Chris Viehbacher admitted that tariffs are “a new topic for us,” but said he ...

Biogen Inc. closed 47.73% short of its 52-week high of $238.00, which the company reached on July 12th.